# Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer

> **NCT00002689** · PHASE2 · COMPLETED · sponsor: **Center for Molecular Medicine** · enrollment: 48 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** fluorouracil
- **RADIATION:** brachytherapy
- **RADIATION:** phosphorus P32
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002689
- **Lead sponsor:** Center for Molecular Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-09
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2013-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002689, "Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT00002689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*